The lack of evidence on the association of polymorphisms of other analysed genes involved in glycaemic regulation (GCK, GCKR, DGKB/AGMO) with the risk of post-transplant diabetes in kidney transplant recipients suggests that they do not play a key role in the development of this type of diabetes. This evidence concerns the gene AGMO and diabetes mellitus.